Related Experiment Video
Updated: Jun 16, 2026

05:30
Isolation, Characterization, and Proteomic Analysis of Plasma-Derived Extracellular Vesicles for Cardiovascular Biomarker Discovery
Published on: January 31, 2025
Statistical analysis of variation in the human plasma proteome
Todd H Corzett1, Imola K Fodor, Megan W Choi
1Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, 7000 East Avenue, Livermore, CA 94550, USA.
Journal of Biomedicine & Biotechnology
|February 5, 2010
Summary
Understanding human plasma proteome variation is key for biomarker discovery. This study quantifies individual and longitudinal differences, identifying proteins that may not be suitable biomarkers.
Area of Science:
- Biochemistry
- Proteomics
- Human Physiology
Background:
- Accurate quantification of human plasma proteome variation is crucial for identifying reliable disease biomarkers.
- Understanding both individual and longitudinal variations is essential for robust biomarker discovery.
Purpose of the Study:
- To quantify the longitudinal and individual variation in the human plasma proteome.
- To identify potential protein candidates for biomarkers and assess their suitability.
Main Methods:
- Two-dimensional difference gel electrophoresis (2-D DIGE) was employed on plasma samples from eleven healthy subjects over two weeks.
- Fixed-effects and mixed-effects modeling were utilized to analyze and quantify sources of proteomic variation.
- Mass spectrometry and hierarchical clustering were used for protein identification and characterization.
Main Results:
- Subject-to-subject variation was the largest component of proteomic variation.
- Time-within-subject variation was comparable to experimental technical variation.
- Twenty-one protein spots exhibited high coefficient of variation (>50%), suggesting caution for biomarker use.
- Seventy-eight differentially expressed protein spots were identified between individuals or collections.
Conclusions:
- This study provides a foundational understanding of human plasma proteome complexity in terms of individual and longitudinal variation.
- The findings offer a baseline for future biomarker discovery efforts, highlighting proteins that require careful scrutiny.
Related Concept Videos
Proteomics
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Composition of Blood Plasma
Blood plasma is a fluid that contains approximately 92% water and 8% solutes. The solutes include various types of proteins, which constitute about 7% of the total solutes in the plasma. The high-molecular-weight proteins—albumins, globulins, and fibrinogen—are essential to plasma function. Albumins, making up about 60% of the plasma proteins, maintain the osmotic balance within blood vessels by preventing excessive water leakage. Additionally, albumins serve as carrier proteins, binding to...
Drug Distribution: Plasma Protein Binding
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...